Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	6-phosphofructokinase activity	PFKL PFKM PFKP	5.44e-07	3	164	3	GO:0003872
GeneOntologyMolecularFunction	fructose-6-phosphate binding	PFKL PFKM PFKP	5.37e-06	5	164	3	GO:0070095
GeneOntologyMolecularFunction	phosphofructokinase activity	PFKL PFKM PFKP	1.86e-05	7	164	3	GO:0008443
GeneOntologyMolecularFunction	kinase activity	HJV GAK ADCK5 GRK4 PFKL PFKM PFKP SGK2 SBK1 CKMT2 PHKA2 LRGUK EGFR EIF2AK4 MAP3K15 PRKCZ TAF1L TOP1	5.91e-05	764	164	18	GO:0016301
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	HJV GAK ADCK5 GRK4 SGK2 SBK1 PHKA2 EGFR EIF2AK4 MAP3K15 PRKCZ TAF1L TOP1	8.34e-05	446	164	13	GO:0004674
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	HJV GAK ADCK5 GRK4 PFKL PFKM PFKP SGK2 SBK1 CKMT2 PHKA2 LRGUK EGFR PARP16 GYS1 EIF2AK4 MAP3K15 PRKCZ TAF1L TOP1	8.97e-05	938	164	20	GO:0016772
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 ANXA6 PCDHB9 CASQ1 CASQ2 ADGRV1 RYR3 ITPR2 SNED1 THBS2 PPP2R3A CDH20 VCAN TNNC2 CDH2 CDH6 DNASE1L3	1.50e-04	749	164	17	GO:0005509
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	HJV GAK ADCK5 GRK4 PFKL PFKM PFKP SGK2 SBK1 PHKA2 EGFR EIF2AK4 MAP3K15 PRKCZ TAF1L TOP1	2.52e-04	709	164	16	GO:0016773
GeneOntologyMolecularFunction	cadherin binding	ABCF3 PUF60 MYO1B OLA1 PFKP CDH20 EGFR PLEC CDH2 CDH6	5.09e-04	339	164	10	GO:0045296
GeneOntologyMolecularFunction	calmodulin binding	MYO1B ADCY1 RYR3 PHKA2 EGFR IQCB1 MYO15A CAMSAP2	6.43e-04	230	164	8	GO:0005516
GeneOntologyMolecularFunction	AMP binding	PFKL PFKM PFKP	6.49e-04	21	164	3	GO:0016208
GeneOntologyMolecularFunction	carbohydrate kinase activity	PFKL PFKM PFKP	6.49e-04	21	164	3	GO:0019200
GeneOntologyMolecularFunction	deoxyribonuclease I activity	DNASE1L1 DNASE1L3	6.60e-04	5	164	2	GO:0004530
GeneOntologyMolecularFunction	fructose binding	PFKL PFKM	9.84e-04	6	164	2	GO:0070061
GeneOntologyCellularComponent	6-phosphofructokinase complex	PFKL PFKM PFKP	5.01e-07	3	167	3	GO:0005945
Domain	6-Pfructokinase_euk	PFKL PFKM PFKP	6.65e-07	3	164	3	IPR009161
Domain	PHOSPHOFRUCTOKINASE	PFKL PFKM PFKP	6.65e-07	3	164	3	PS00433
Domain	Phosphofructokinase_CS	PFKL PFKM PFKP	6.65e-07	3	164	3	IPR015912
Domain	PFK	PFKL PFKM PFKP	6.65e-07	3	164	3	PF00365
Domain	ATP_PFK	PFKL PFKM PFKP	6.65e-07	3	164	3	IPR022953
Domain	Phosphofructokinase_dom	PFKL PFKM PFKP	6.65e-07	3	164	3	IPR000023
Domain	Med13_N	MED13L MED13	7.66e-05	2	164	2	PF11597
Domain	Mediator_Med13_N_met/fun	MED13L MED13	7.66e-05	2	164	2	IPR021643
Domain	Calsequestrin_CS	CASQ1 CASQ2	7.66e-05	2	164	2	IPR018233
Domain	Calsequestrin	CASQ1 CASQ2	7.66e-05	2	164	2	PF01216
Domain	Med13_C	MED13L MED13	7.66e-05	2	164	2	PF06333
Domain	CALSEQUESTRIN_1	CASQ1 CASQ2	7.66e-05	2	164	2	PS00863
Domain	CALSEQUESTRIN_2	CASQ1 CASQ2	7.66e-05	2	164	2	PS00864
Domain	Mediator_Med13	MED13L MED13	7.66e-05	2	164	2	IPR009401
Domain	HTH_Tnp_Tc5	DCHS2 POGK TIGD4	1.78e-04	13	164	3	PF03221
Domain	IQ	RASGRF1 MYO9A MYO1B IQCB1 MYO15A	4.01e-04	71	164	5	PF00612
Domain	Deoxyribonuclease-1_AS	DNASE1L1 DNASE1L3	4.55e-04	4	164	2	IPR018057
Domain	DNASE_I_2	DNASE1L1 DNASE1L3	4.55e-04	4	164	2	PS00918
Domain	DNASE_I_1	DNASE1L1 DNASE1L3	4.55e-04	4	164	2	PS00919
Domain	DNaseIc	DNASE1L1 DNASE1L3	4.55e-04	4	164	2	SM00476
Domain	DNASE_I_2	DNASE1L1 DNASE1L3	4.55e-04	4	164	2	IPR033125
Domain	DNase_I	DNASE1L1 DNASE1L3	4.55e-04	4	164	2	IPR016202
Domain	Calsequestrin	CASQ1 CASQ2	4.55e-04	4	164	2	IPR001393
Domain	IQ	RASGRF1 MYO9A MYO1B IQCB1 MYO15A	7.35e-04	81	164	5	SM00015
Domain	RIH_assoc-dom	RYR3 ITPR2	1.12e-03	6	164	2	IPR013662
Domain	Ins145_P3_rec	RYR3 ITPR2	1.12e-03	6	164	2	PF08709
Domain	RIH_assoc	RYR3 ITPR2	1.12e-03	6	164	2	PF08454
Domain	RIH_dom	RYR3 ITPR2	1.12e-03	6	164	2	IPR000699
Domain	Ins145_P3_rcpt	RYR3 ITPR2	1.12e-03	6	164	2	IPR014821
Domain	Ryanodine_recept-rel	RYR3 ITPR2	1.12e-03	6	164	2	IPR015925
Domain	-	RYR3 ITPR2	1.12e-03	6	164	2	1.25.10.30
Domain	RYDR_ITPR	RYR3 ITPR2	1.12e-03	6	164	2	PF01365
Domain	FG-GAP	BBS2 ITGA3 ITGAV	1.17e-03	24	164	3	PF01839
Domain	FG-GAP	BBS2 ITGA3 ITGAV	1.17e-03	24	164	3	IPR013517
Domain	IQ_motif_EF-hand-BS	RASGRF1 MYO9A MYO1B IQCB1 MYO15A	1.18e-03	90	164	5	IPR000048
Domain	CCP	CSMD2 CR1 SNED1 VCAN	1.29e-03	54	164	4	SM00032
Domain	Cadherin_C	CDH20 CDH2 CDH6	1.33e-03	25	164	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH20 CDH2 CDH6	1.33e-03	25	164	3	IPR000233
Domain	IQ	RASGRF1 MYO9A MYO1B IQCB1 MYO15A	1.37e-03	93	164	5	PS50096
Domain	SUSHI	CSMD2 CR1 SNED1 VCAN	1.48e-03	56	164	4	PS50923
Domain	RIIa	RIIAD1 PRKAR2B	1.56e-03	7	164	2	PF02197
Domain	Sushi_SCR_CCP_dom	CSMD2 CR1 SNED1 VCAN	1.58e-03	57	164	4	IPR000436
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	GRK4 ANXA6 CASQ1 CASQ2 ADCY1 RYR3 ITPR2 PRKAR2B PRKCZ	7.11e-06	147	127	9	MM15854
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	GRK4 ANXA6 CASQ1 CASQ2 ADCY1 RYR3 ITPR2 PRKAR2B PRKCZ	8.84e-06	151	127	9	M39329
Pathway	BIOCARTA_PTDINS_PATHWAY	PFKL PFKM PFKP PRKCZ	4.87e-05	23	127	4	M8809
Pathway	WP_HIPPOMERLIN_SIGNALING_DYSREGULATION	ITGA3 ITGAV CDH20 EGFR PRKAR2B CDH2 CDH6	1.10e-04	121	127	7	M39823
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MIA3 MYO9A PSMA1 ANXA6 SIPA1L3 RALGAPB TP53I11 CPD FRYL ADGRV1 PFKL UBN2 ADCY1 JMJD1C GALNT18 SGK2 SBK1 PPARGC1B PPP2R3A FAM13A EGFR RRP36 LMLN EIF2AK4 PRKCZ PRORP LRRC41	3.71e-09	1489	169	27	28611215
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	PFKL PFKM PFKP PAF1 EFTUD2 RIF1 SMC3 BAZ1A GYS1 PLEC HNRNPLL AHNAK2	9.37e-08	332	169	12	32786267
Pubmed	Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.	PFKL PFKM PFKP	1.13e-07	3	169	3	7825568
Pubmed	Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.	PFKL PFKM PFKP	1.13e-07	3	169	3	6444721
Pubmed	Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches.	PFKL PFKM PFKP	1.13e-07	3	169	3	33141153
Pubmed	Genomic organization, 5'flanking region and tissue-specific expression of mouse phosphofructokinase C gene.	PFKL PFKM PFKP	1.13e-07	3	169	3	11137296
Pubmed	Phosphofructokinase isozyme expression during myoblast differentiation.	PFKL PFKM PFKP	1.13e-07	3	169	3	2521854
Pubmed	Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues.	PFKL PFKM PFKP	1.13e-07	3	169	3	156693
Pubmed	Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system.	PFKL PFKM PFKP	1.13e-07	3	169	3	6451249
Pubmed	Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.	PFKL PFKM PFKP	1.13e-07	3	169	3	2960695
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TANC2 ABCF3 PUF60 U2SURP OLA1 PFKM PFKP EFTUD2 RIF1 VPS33B SMC3 SF3A3 PLEC HNRNPLL TOP1	1.87e-07	582	169	15	20467437
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ABCF3 PUF60 PSMA1 SIPA1L3 U2SURP MYO1B RIOX1 PFKL OLA1 MED13L PFKM PFKP GDI2 LANCL2 EFTUD2 KANK1 SMC3 PRKCZ CAMSAP2 HNRNPLL TOP1 MED13	1.92e-07	1247	169	22	27684187
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 MYO9A SIPA1L3 RALGAPB SPATA18 FRYL PTPN21 PFKP CDC14A USP31 ZNF106 FAM13A IQCB1 OSBPL8 AKAP11 PLEC CAMSAP2 AHNAK2	2.40e-07	861	169	18	36931259
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HNRNPDL PUF60 PSMA1 ANXA6 RGS22 U2SURP SPATA18 MYO1B PFKL OLA1 PFKM GDI2 LANCL2 EFTUD2 UBE4A RIF1 VPS33B SMC3 BAZ1A SF3A3 HNRNPLL TOP1 MYBPC1	4.69e-07	1425	169	23	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HNRNPDL GARIN5B SIPA1L3 U2SURP GOLGA6D MYO1B GOLGA6A PTPN21 PFKM PFKP UQCR10 CXXC1 CLCN4 RRP36 BAZ1A LMLN EIF2AK4 PLEC CAMSAP2 POFUT2 TOP1 MED13 MYBPC1	5.75e-07	1442	169	23	35575683
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L TANC2 SIPA1L3 ZNF407 UBN2 JMJD1C EFTUD2 UBE4A DNAH17 HELZ2 OSBPL8 PRORP ADAMTSL2	9.84e-07	493	169	13	15368895
Pubmed	A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy.	PSMA1 ANXA6 ITGA3 PFKP GDI2	1.46e-06	40	169	5	36527092
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	GAK MIA3 PSMA1 U2SURP MYO1B CPD ITGA3 PFKM PFKP UQCR10 ITGAV LANCL2 PAIP1 ZNF106 EGFR SMC3 BAZ1A GYS1 OSBPL8 POFUT2 TOP1	1.47e-06	1297	169	21	33545068
Pubmed	Common and distinctive localization patterns of Crumbs polarity complex proteins in the mammalian eye.	GOLGA6D GOLGA6A PRKCZ CDH2	4.43e-06	23	169	4	25636444
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HNRNPDL ABCF3 PUF60 PSMA1 U2SURP PFKL OLA1 PFKM PFKP PAF1 LANCL2 EFTUD2 RIF1 EGFR SMC3 SF3A3 OSBPL8 MRPL41 PLEC TOP1 AHNAK2	5.69e-06	1415	169	21	28515276
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	CASQ1 CASQ2 RYR3	6.20e-06	8	169	3	11784029
Pubmed	Proteomic analysis of the 20S proteasome (PSMA3)-interacting proteins reveals a functional link between the proteasome and mRNA metabolism.	PUF60 PSMA1 PAF1 EFTUD2 SF3A3 HNRNPLL	6.47e-06	93	169	6	22079093
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	MYO1B MED13L PFKP EFTUD2 RIF1 SMC3 OSBPL8 PLEC MED13	8.05e-06	272	169	9	31010829
Pubmed	Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.	TANC2 PFKL PFKM PFKP PRKAR2B PLEC CAMSAP2	8.12e-06	147	169	7	16959763
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	DGCR2 GAK GALC U2SURP CPD PFKL ACSF2 PFKM PFKP CR1 UQCR10 ITGAV EFTUD2 SNED1 THBS2 EGFR SF3A3 MRPL41 PLEC POFUT2 TOP1	8.32e-06	1451	169	21	30550785
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	HNRNPDL ANXA6 MYO1B RIOX1 PFKL ITGA3 OLA1 PFKM PFKP GDI2 EFTUD2 SMC3 HELZ2 PLEC TOP1	9.78e-06	803	169	15	36517590
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HNRNPDL ABCF3 SPOUT1 MYO9A PSMA1 U2SURP MYO1B PFKL PFKM PFKP CXXC1 EFTUD2 RIF1 VPS33B SMC3 BAZ1A SF3A3 PLEC TOP1 AHNAK2	1.02e-05	1353	169	20	29467282
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HNRNPDL PUF60 ANXA6 U2SURP MYO1B PFKL OLA1 PFKP ITPR2 EFTUD2 RIF1 SMC3 RRP36 BAZ1A SF3A3 PLEC TOP1	1.14e-05	1024	169	17	24711643
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	U2SURP FRYL OLA1 EFTUD2 KANK1 BAZ1A GYS1	1.20e-05	156	169	7	22952844
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	HNRNPDL PUF60 PSMA1 U2SURP MYO1B PFKL PFKP PAF1 GDI2 EFTUD2 PHKA2 SMC3 GYS1 IQCB1 SF3A3 PRKAR2B PLEC TOP1	1.36e-05	1149	169	18	35446349
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GAK PUF60 U2SURP MYO1B PFKL PFKM PFKP PAF1 EFTUD2 IBTK RIF1 BAZ1A CAMSAP2 TOP1 RSBN1L AHNAK2	1.43e-05	934	169	16	33916271
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	GALC MYO9A PUF60 PSMA1 SIPA1L3 PFKL OLA1 MED13L GDI2 ITPR2 MFAP4 HELZ2 MRPL41 RSPH10B	1.51e-05	732	169	14	34732716
Pubmed	Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.	GOLGA6D GOLGA6A PRKCZ ADAMTSL2	1.53e-05	31	169	4	25762570
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MIA3 SIPA1L3 RALGAPB MYO1B BCKDHB CPD PTPN21 PAF1 CDC14A ITPR2 USP31 RIF1 PPP2R3A VPS33B EGFR PLCL2 EIF2AK4	1.55e-05	1049	169	17	27880917
Pubmed	Defining the membrane proteome of NK cells.	GAK MIA3 ABCF3 HLA-DQB1 ANXA6 CPD PFKL OLA1 PFKP ITPR2 EFTUD2 PARP16 GYS1 HELZ2 OSBPL8 HNRNPLL MED13 LRRC41	1.69e-05	1168	169	18	19946888
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MYO1B CPD PFKM PAF1 EFTUD2 UBE4A VPS33B SMC3 BAZ1A OSBPL8 PRKAR2B LRRC41	2.08e-05	560	169	12	35241646
Pubmed	Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.	ANXA6 EGFR	2.35e-05	2	169	2	24354805
Pubmed	PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells.	PTPN21 EGFR	2.35e-05	2	169	2	20923765
Pubmed	Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms.	PFKL PFKM	2.35e-05	2	169	2	29655163
Pubmed	Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex.	ADCY1 PRKCZ	2.35e-05	2	169	2	21127255
Pubmed	Calsequestrin depolymerizes when calcium is depleted in the sarcoplasmic reticulum of working muscle.	CASQ1 CASQ2	2.35e-05	2	169	2	28069951
Pubmed	Overexpression of JKTBP1 induces androgen-independent LNCaP cell proliferation through activation of epidermal growth factor-receptor (EGF-R).	HNRNPDL EGFR	2.35e-05	2	169	2	18381662
Pubmed	Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.	EGFR VCAN	2.35e-05	2	169	2	21079779
Pubmed	The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy.	PFKL PFKM	2.35e-05	2	169	2	6444532
Pubmed	Cdc14: a highly conserved family of phosphatases with non-conserved functions?	CDC14C CDC14A	2.35e-05	2	169	2	20720150
Pubmed	Calsequestrin Deletion Facilitates Hippocampal Synaptic Plasticity and Spatial Learning in Post-Natal Development.	CASQ1 CASQ2	2.35e-05	2	169	2	32751833
Pubmed	C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.	CEBPA EGFR	2.35e-05	2	169	2	27050434
Pubmed	Knocking down type 2 but not type 1 calsequestrin reduces calcium sequestration and release in C2C12 skeletal muscle myotubes.	CASQ1 CASQ2	2.35e-05	2	169	2	16595676
Pubmed	hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.	POU5F1 PAF1	2.35e-05	2	169	2	28122356
Pubmed	Paradoxical buffering of calcium by calsequestrin demonstrated for the calcium store of skeletal muscle.	CASQ1 CASQ2	2.35e-05	2	169	2	20713548
Pubmed	Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors.	ANXA6 EGFR	2.35e-05	2	169	2	30590459
Pubmed	The glycolytic enzyme phosphofructokinase-1 assembles into filaments.	PFKL PFKM	2.35e-05	2	169	2	28646105
Pubmed	Cloning of human muscle phosphofructokinase cDNA.	PFKM PFKP	2.35e-05	2	169	2	2822475
Pubmed	Revealing membrane alteration in cellsoverexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering.	CA9 EGFR	2.35e-05	2	169	2	30755643
Pubmed	Mitochondrial Ca2+-handling in fast skeletal muscle fibers from wild type and calsequestrin-null mice.	CASQ1 CASQ2	2.35e-05	2	169	2	24098358
Pubmed	Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor.	EGFR VCAN	2.35e-05	2	169	2	16648628
Pubmed	Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.	PFKL PFKM	2.35e-05	2	169	2	8780720
Pubmed	Differential skeletal muscle proteome of high- and low-active mice.	ANXA6 CASQ1	2.35e-05	2	169	2	24505100
Pubmed	The Histone Demethylase NO66 Induces Glioma Cell Proliferation.	RIOX1 EGFR	2.35e-05	2	169	2	31704826
Pubmed	Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.	PFKM PFKP	2.35e-05	2	169	2	25985179
Pubmed	Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.	ITGA3 ITGAV	2.35e-05	2	169	2	20926544
Pubmed	Activation by tyrosine phosphorylation as a prerequisite for protein kinase Cζ to mediate epidermal growth factor receptor signaling to ERK.	EGFR PRKCZ	2.35e-05	2	169	2	20407013
Pubmed	Mediator complex component MED13 regulates zygotic genome activation and is required for postimplantation development in the mouse.	MED13L MED13	2.35e-05	2	169	2	29325037
Pubmed	Cloning of the genes encoding mouse cardiac and skeletal calsequestrins: expression pattern during embryogenesis.	CASQ1 CASQ2	2.35e-05	2	169	2	9795116
Pubmed	Differential effect of calsequestrin ablation on structure and function of fast and slow skeletal muscle fibers.	CASQ1 CASQ2	2.35e-05	2	169	2	21941434
Pubmed	Endogenous and maximal sarcoplasmic reticulum calcium content and calsequestrin expression in type I and type II human skeletal muscle fibres.	CASQ1 CASQ2	2.35e-05	2	169	2	24127619
Pubmed	Gene mutation analysis in Iranian children with nephronophthisis: a two-center study.	NPHP1 IQCB1	2.35e-05	2	169	2	25851290
Pubmed	Chimeric phosphofructokinases involving exchange of the N- and C-terminal halves of mammalian isozymes: implications for ligand binding sites.	PFKM PFKP	2.35e-05	2	169	2	17544406
Pubmed	Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.	EGFR OSMR	2.35e-05	2	169	2	27110918
Pubmed	Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients.	LANCL2 EGFR	2.35e-05	2	169	2	34461927
Pubmed	SLMAP3 is essential for neurulation through mechanisms involving cytoskeletal elements, ABP, and PCP.	GOLGA6D GOLGA6A PRKCZ CDH2	2.50e-05	35	169	4	39366759
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L NPHP1 TANC2 GALC BBS2 BCKDHB OLA1 PFKP ITGAV EFTUD2 RIF1 SMC3 GYS1 IQCB1 PLCL2 SF3A3 PLEC CAMSAP2 RSPH10B	2.52e-05	1321	169	19	27173435
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	HNRNPDL SPOUT1 PSMA1 U2SURP MYO1B RIOX1 PAF1 JMJD1C EFTUD2 ZNF106 RIF1 SMC3 SF3A3 PLEC TOP1 RSBN1L	2.85e-05	989	169	16	36424410
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	HNRNPDL CEBPA PUF60 PSMA1 ANXA6 U2SURP PFKL OLA1 MED13L PFKM PAF1 UBN2 GDI2 JMJD1C SMC3 HNRNPLL TOP1	2.93e-05	1103	169	17	34189442
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	POU5F1 THBS2 ADAMTS7 POFUT2 ADAMTSL2	3.35e-05	75	169	5	20637190
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	PUF60 PSMA1 OLA1 MED13L PFKP PAF1 GDI2 RIF1 MFAP4 SMC3 BAZ1A PLEC MYO15A HNRNPLL TOP1 MED13	3.84e-05	1014	169	16	32416067
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DGCR2 GAK MIA3 RALGAPB BBS2 BCKDHB CPD PFKM PFKP PAF1 ITPR2 EFTUD2 USP31 UBE4A EGFR OSBPL8 PRKAR2B MRPL41 AKAP11 LRRC41	3.92e-05	1487	169	20	33957083
Pubmed	Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.	VCAN CDH2 POFUT2	3.94e-05	14	169	3	27687499
Pubmed	Trophectoderm mechanics direct epiblast shape upon embryo implantation.	LAMA1 POU5F1 CDH2	3.94e-05	14	169	3	33472064
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SECISBP2L CEBPA SPOUT1 PUF60 ANXA6 SIPA1L3 MYO1B RIOX1 OLA1 ITGAV IBTK RIF1 BAZ1A HELZ2 OSBPL8 EIF2AK4 PLEC TOP1 RSBN1L	4.15e-05	1371	169	19	36244648
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	HNRNPDL PSMA1 GOLGA6D GOLGA6A PFKP LANCL2 ITPR2 CD22 SMC3 HELZ2 OSBPL8 PLEC TOP1	4.20e-05	701	169	13	30196744
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	MIA3 PUF60 MUC19 WDR81 MYO1B OLA1 PFKP UQCR10 GDI2 EFTUD2 PLEC MYO15A TOP1 AHNAK2	4.37e-05	807	169	14	30575818
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	HNRNPDL SPOUT1 PUF60 PSMA1 SIPA1L3 MYO1B PFKL PFKP LANCL2 ITPR2 EFTUD2 EGFR SMC3 HELZ2 SF3A3 PLEC TOP1 RSBN1L	4.40e-05	1257	169	18	36526897
Pubmed	Differential Spatiotemporal Expression of Type I and Type II Cadherins Associated With the Segmentation of the Central Nervous System and Formation of Brain Nuclei in the Developing Mouse.	CDH20 CDH2 CDH6	4.91e-05	15	169	3	33833667
Pubmed	Three-dimensional visualization of testis cord morphogenesis, a novel tubulogenic mechanism in development.	NPHP1 LAMA1 CASQ2 POU5F1 RIF1 MFAP4 VCAN	5.18e-05	196	169	7	19334288
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	GAK SPOUT1 PUF60 U2SURP OLA1 PLEC TAF1L TOP1	5.51e-05	269	169	8	29511261
Pubmed	Suppression of C/EBPalpha expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 and Hnf1b expression.	CEBPA ITGA3 CDH2	6.03e-05	16	169	3	17021047
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	LAMA1 POU5F1 PAF1 JMJD1C RIF1 SF3A3 TAF1L	6.46e-05	203	169	7	22083510
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAK MIA3 TP53I11 PAIP1 JMJD1C ITPR2 ZNF106 IBTK KANK1 IQCB1 SF3A3 OSBPL8 RSBN1L	6.60e-05	733	169	13	34672954
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	SIPA1L3 ZNF407 FRYL MED13L PAIP1 JMJD1C RIF1 KANK1 KDM4A POFUT2 MED13	6.81e-05	536	169	11	15840001
Pubmed	The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin.	NPHP1 IQCB1	7.02e-05	3	169	2	12244321
Pubmed	Role of the JP45-Calsequestrin Complex on Calcium Entry in Slow Twitch Skeletal Muscles.	CASQ1 CASQ2	7.02e-05	3	169	2	27189940
Pubmed	Human Adenovirus Type 37 Uses αVβ1 and α3β1 Integrins for Infection of Human Corneal Cells.	ITGA3 ITGAV	7.02e-05	3	169	2	27974569
Pubmed	Formation of corneal endothelium is essential for anterior segment development - a transgenic mouse model of anterior segment dysgenesis.	EGFR CDH2	7.02e-05	3	169	2	10631174
Pubmed	SENIOR-LØKEN SYNDROME: A Case Series and Review of the Renoretinal Phenotype and Advances of Molecular Diagnosis.	NPHP1 IQCB1	7.02e-05	3	169	2	33512896
Pubmed	Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration.	EGFR CDH2	7.02e-05	3	169	2	22102727
Pubmed	[Grape seed proanthocyanidins inhibits the invasion and migration of A549 lung cancer cells].	EGFR CDH2	7.02e-05	3	169	2	26927375
Pubmed	[Functional Hypermethylation of ALDH1L1, PLCL2, and PPP2R3A in Colon Cancer].	PPP2R3A PLCL2	7.02e-05	3	169	2	32392189
Pubmed	Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.	CA9 EGFR	7.02e-05	3	169	2	21966417
Pubmed	D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.	ITGAV EGFR	7.02e-05	3	169	2	29184982
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CR1 SNED1 VCAN	3.60e-04	57	107	4	1179
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SECISBP2L HNRNPDL U2SURP MYO1B FRYL MED13L PAIP1 IBTK RIF1 THBS2 PPP2R3A EGFR SMC3 BAZ1A OSBPL8 AKAP11 OSMR CAMSAP2 CDH2 TOP1 MED13	1.51e-07	856	168	21	M4500
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	SECISBP2L HNRNPDL DGCR2 MIA3 SPOUT1 PSMA1 U2SURP RIOX1 CPD ACSF2 UQCR10 ITGAV PAIP1 RYR3 ITPR2 UBE4A ZNF106 IBTK FAM13A BAZ1A PLCL2 OSBPL8 KDM4A DNASE1L3	9.45e-07	1215	168	24	M41122
Coexpression	BAELDE_DIABETIC_NEPHROPATHY_DN	HNRNPDL N4BP2L1 GALC MYO1B ITGA3 CR1 ITGAV CDC14A KANK1 VCAN PRKAR2B AKAP11 OSMR CAMSAP2	9.50e-07	437	168	14	M4665
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	HNRNPDL U2SURP MYO1B FRYL MED13L PAIP1 IBTK THBS2 PPP2R3A EGFR BAZ1A OSBPL8 CAMSAP2 MED13	2.02e-06	466	168	14	M13522
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SECISBP2L TANC2 MIA3 APBA1 MUC19 MED13L PFKP CSMD2 UBN2 LANCL2 ADCY1 SGK2 SBK1 PPARGC1B PPP2R3A CLCN4 VCAN PRKAR2B PRKCZ CAMSAP2 AHNAK2	8.80e-06	1106	168	21	M39071
Coexpression	JI_RESPONSE_TO_FSH_DN	GDI2 VCAN PLEC OSMR TOP1	2.28e-05	53	168	5	M17537
Coexpression	GOZGIT_ESR1_TARGETS_UP	CEBPA POU5F1 PTPN21 ACSF2 FAM13A PLCL2 PRKAR2B	5.13e-05	149	168	7	M13944
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_100	CASQ1 RYR3 P2RX1 TNNC2 AHNAK2	6.18e-06	34	165	5	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500	CASQ1 CASQ2 PFKP RYR3 THBS2 P2RX1 TNNC2	3.26e-05	115	165	7	gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200	CASQ1 CASQ2 PFKP RYR3 THBS2 P2RX1 TNNC2 AHNAK2	4.38e-05	164	165	8	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500	ANXA6 CASQ1 CASQ2 PFKP GDI2 RYR3 THBS2 KANK1 P2RX1 TNNC2 OSMR AHNAK2	4.86e-05	384	165	12	gudmap_developingLowerUrinaryTract_P1_bladder_500_B
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV SPATA18 CASQ1 CASQ2 PFKM CKMT2 SLCO1C1 TNNC2 CDH6	3.39e-08	183	168	9	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CASQ1 CASQ2 PFKM UQCR10 CKMT2 MRPL41 TNNC2 CDH2 MYBPC1	6.39e-08	197	168	9	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC29A3 CEBPA NHLRC3 CDC14A USP31 LMLN MRPL41 DNASE1L3	7.01e-08	142	168	8	0a87c0d74e281da5dc4f59e09a5e99c62b1ea801
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	MYO9A GRK4 ADGRV1 PTPN21 PAIP1 VCAN OSBPL8 EIF2AK4	3.20e-07	173	168	8	42c911ed16fabdabef063830e8407192d8bde950
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV TIGD4 CASQ1 PFKM CKMT2 GYS1 TNNC2 MYBPC1	5.33e-07	185	168	8	9245c322aae8bb9065d50dada198a5ee143a3444
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA1 MUC19 CPD ADGRV1 CSMD2 ADCY1 RYR3 MYO15A	7.93e-07	195	168	8	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA1 MUC19 CPD ADGRV1 CSMD2 ADCY1 RYR3 MYO15A	7.93e-07	195	168	8	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	MYO1B CPD CDC14A JMJD1C BAZ1A OSBPL8 PRORP HNRNPLL	8.24e-07	196	168	8	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 MYO9A SIPA1L3 ZNF407 ADGRV1 MED13L KANK1 EGFR	8.89e-07	198	168	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CA9 ITGA3 TGM6 PFKP GYS1 PLEC OSMR AHNAK2	9.24e-07	199	168	8	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAM89A CDC14A ITPR2 RLBP1 KANK1 ADAMTS7 VCAN	1.01e-06	139	168	7	a957ea4e581646c76b16b6a7f89579b8c7ac35b6
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SECISBP2L GALC CEBPA RYR3 LMLN IQCB1 CAMSAP2	2.92e-06	163	168	7	d2fcd6f561748f7d29a051c504f016952ba32d0f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A LAMA1 POU5F1 RYR3 PPP2R3A VCAN CDH6	3.04e-06	164	168	7	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	facs-Marrow-B-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEBPA GRK4 HEPACAM2 PFKP P2RX1 CLCN4 DNAH17	3.29e-06	166	168	7	13027ae342994db4540e64eb910df1f42b160931
ToppCell	facs-Marrow-B-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEBPA GRK4 HEPACAM2 PFKP P2RX1 CLCN4 DNAH17	3.29e-06	166	168	7	b21e45bd43f26149b9cd6e45c19241c82d54fb2f
ToppCell	PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANXA6 PPARGC1B VPS33B LMLN PLCL2 PRORP DNASE1L3	3.70e-06	169	168	7	3e40ae0b23a962e0f15908872dec63f51c5b8b83
ToppCell	droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 HEPACAM2 PFKP SGK2 SNED1 TNNC2 DNASE1L3	3.70e-06	169	168	7	149a4f83da15bdeb170e980fb5b5b1af89ae07a6
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 CDC14A RLBP1 KANK1 SLCO1C1 VCAN	4.16e-06	172	168	7	55fba5ce0ead1114e1a76f67ad68432c6bac90e5
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ1 PFKM CKMT2 GYS1 TNNC2 MYBPC1	4.49e-06	174	168	7	4a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM89A PCDHB9 RLBP1 KCND1 TMEM179 VCAN B3GAT2	4.84e-06	176	168	7	ef0ff02897104e938c8a632357d8f1a6f014e68a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM89A PCDHB9 RLBP1 KCND1 TMEM179 VCAN B3GAT2	4.84e-06	176	168	7	da0983929fa682a68e536c298a2d7add188b7563
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 MYO9A JMJD1C ZNF106 IBTK MFAP4 ADAMTSL2	4.84e-06	176	168	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ1 TPBGL PFKM CKMT2 TNNC2 MYBPC1	5.02e-06	177	168	7	f6ff1b035fa2418f2448c99d81faa927ece93dfa
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA3 CSMD2 ITGAV RYR3 PLEC CDH2 CDH6	5.21e-06	178	168	7	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV TIGD4 CASQ1 PFKM CKMT2 TNNC2 MYBPC1	5.61e-06	180	168	7	cea62fc006d68c3815c88bf17ec2617d7e41c3d2
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ1 PFKM CKMT2 GYS1 TNNC2 MYBPC1	6.03e-06	182	168	7	edfc598b7199ca1d8a399b264ab863c299b1eede
ToppCell	facs-Heart-LA-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ2 PFKM UQCR10 CKMT2 PPP2R3A CDH20	6.25e-06	183	168	7	905e1e9be0f15be184447df04b134a6aa8279074
ToppCell	facs-Heart-LA-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ2 PFKM UQCR10 CKMT2 PPP2R3A CDH20	6.25e-06	183	168	7	92eed783347a372b850de3189e72525082390014
ToppCell	LA-11._Adipocyte\|LA / Chamber and Cluster_Paper	FAM89A PSMA1 BCKDHB ACSF2 SGK2 PPARGC1B PRKAR2B	6.25e-06	183	168	7	3f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCell	COVID-19-kidney-Podocyte\|kidney / Disease (COVID-19 only), tissue and cell type	FAM89A SPATA18 APBA1 CR1 CDC14A RYR3 PRKAR2B	6.25e-06	183	168	7	fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A KANK1 SLCO1C1 VCAN	6.47e-06	184	168	7	22c18964818fc9c8f18051f836d718937b0d8d12
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PFKP ITGAV GALNT18 RYR3 SNED1 THBS2 VCAN	6.71e-06	185	168	7	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RGS22 MUC19 ADGRV1 MED13L JMJD1C VCAN PLEC	6.95e-06	186	168	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	7.20e-06	187	168	7	4d2115a05ec36dd179ca1d4a525f2d4501aea557
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	7.20e-06	187	168	7	93c78fc7f126132eb84feb47be2c4e8c568b9e91
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO9A LAMA1 CPD ADGRV1 PPP2R3A CDH6	7.45e-06	188	168	7	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HJV CASQ1 CASQ2 TNNC2 OSMR CDH6 MYBPC1	7.45e-06	188	168	7	b01cb642f8b2d83235706fec7477c15005094161
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ1 PFKM CKMT2 GYS1 TNNC2 MYBPC1	7.71e-06	189	168	7	d2b008f98739c6af7ee63b643011a240db20e4d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO9A LAMA1 CPD ADGRV1 ITGA3 PPP2R3A	7.98e-06	190	168	7	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	7.98e-06	190	168	7	3a55cc5dc2549788bfe55f649686887b21a1fdd2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO9A LAMA1 CPD ADGRV1 ITGA3 PPP2R3A	7.98e-06	190	168	7	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 STON1 SNED1 KANK1 IQCB1 PRKCZ OSMR	7.98e-06	190	168	7	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	7.98e-06	190	168	7	b56c55f608b30f7379941ac7d5f0f5200f305fca
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	7.98e-06	190	168	7	1c3d601422efa60fad8565f9ccd9032b847e4a91
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A LAMA1 GALNT18 PPP2R3A KANK1 EGFR CDH2	8.26e-06	191	168	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 MYO9A LAMA1 CPD ADGRV1 ITGA3 PPP2R3A	8.26e-06	191	168	7	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	SECISBP2L MYO1B ADGRV1 ITGA3 KANK1 EGFR PRKCZ	8.26e-06	191	168	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ1 CASQ2 MYO1B PFKM CKMT2 TNNC2	8.26e-06	191	168	7	f932980baa032748857cb367a55c37dd975c693e
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ2 PFKM ADCY1 RYR3 CKMT2 CDH2	8.26e-06	191	168	7	97fb4232417a39801e87725755fd16a57c250209
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 CDC14A ITPR2 KANK1 CDH20 SLCO1C1 CD22	8.26e-06	191	168	7	f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ2 PFKM ADCY1 RYR3 CKMT2 CDH2	8.26e-06	191	168	7	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	8.55e-06	192	168	7	43beaac1de99b9c1a6dab4a450b4e81286987b64
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MYO1B ADGRV1 ITGA3 KANK1 EGFR PRKCZ OSMR	8.55e-06	192	168	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	8.84e-06	193	168	7	b03d908d4b8940927f72c76a1b0f237d13f39056
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 ACSF2 CDC14A RLBP1 KANK1 SLCO1C1	8.84e-06	193	168	7	40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO9A MYO1B ADGRV1 ITGA3 KANK1 EGFR PRKCZ	9.46e-06	195	168	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	MYO1B ADGRV1 ITGA3 KANK1 EGFR PRKCZ OSMR	9.46e-06	195	168	7	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 MYO9A SIPA1L3 ZNF407 ADGRV1 MED13L KANK1	9.78e-06	196	168	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19-Heart-Mito_CM\|Heart / Disease (COVID-19 only), tissue and cell type	CASQ1 PFKM UQCR10 ZNF106 MRPL41 TNNC2 MYBPC1	1.04e-05	198	168	7	b6cd439863d17209b86dc50ae51282dc1725955d
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MYO1B SNED1 MFAP4 THBS2 EGFR VCAN OSMR	1.04e-05	198	168	7	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 MYO9A MYO1B ADGRV1 KANK1 EGFR PRKCZ	1.08e-05	199	168	7	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MYO1B SNED1 MFAP4 THBS2 EGFR VCAN OSMR	1.08e-05	199	168	7	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9A SIPA1L3 MYO1B ADGRV1 KANK1 EGFR PRKCZ	1.08e-05	199	168	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 BBS2 ADGRV1 RYR3 RLBP1 SLCO1C1 MYBPC1	1.11e-05	200	168	7	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	Macroglial-Astrocytes-GFAP---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 ADGRV1 RYR3 SNED1 CKMT2 PLEC MYBPC1	1.11e-05	200	168	7	88d66550781a3c9102ff7455f5cff6fb072943cd
ToppCell	Macroglial-Astrocytes-GFAP-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 ADGRV1 RYR3 SNED1 CKMT2 PLEC MYBPC1	1.11e-05	200	168	7	d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCell	Macroglial-Astrocytes-GFAP--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 ADGRV1 RYR3 SNED1 CKMT2 PLEC MYBPC1	1.11e-05	200	168	7	16269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCell	Macroglial-Astrocytes-GFAP----L1-2\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 ADGRV1 RYR3 SNED1 CKMT2 PLEC MYBPC1	1.11e-05	200	168	7	c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
ToppCell	Macroglial-Astrocytes-GFAP\|Macroglial / cells hierarchy compared to all cells using T-Statistic	LAMA1 ADGRV1 RYR3 SNED1 CKMT2 PLEC MYBPC1	1.11e-05	200	168	7	79634b1086934412ae92f259ab43554ce545008f
ToppCell	21-Trachea-Immune-Immune\|Trachea / Age, Tissue, Lineage and Cell class	CA9 DCHS2 MUC19 ADCY1 RRP36 DNASE1L1	1.20e-05	134	168	6	4f0465324cc5b443ebadb68aef63be79b74f6ff9
ToppCell	Entopeduncular-Macroglia-POLYDENDROCYTE\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SECISBP2L FAM89A PCDHB9 SGK2 PPP2R3A KANK1	1.95e-05	146	168	6	a317f14a1aab11ffcce65baeb1c475c04324315f
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FAM89A HEPACAM2 RLBP1 VCAN MYBPC1	1.97e-05	87	168	5	8ca87e4a332ef6f035b13e80dcc0110f32172c9a
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FAM89A HEPACAM2 RLBP1 VCAN MYBPC1	1.97e-05	87	168	5	4ec3a9489981ed69061c1ca363271edf6a3635d2
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FAM89A ITPR2 SGK2 KANK1 VCAN MYBPC1	2.27e-05	150	168	6	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA18 HEPACAM2 SBK1 CD22 PRKCZ DNASE1L3	3.04e-05	158	168	6	66c011e9de002224f70725dfe8e7871c8d304492
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51D TP53I11 SBK1 USP31 CD22 DNASE1L3	3.88e-05	165	168	6	22293c6b55f44636440cd737efb786ff5de3373d
ToppCell	facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAMD1 UPB1 CEBPA LANCL2 ZNF106 CD22	4.01e-05	166	168	6	5c132f505dc5f699c87913f140344fc9f8e7e0f5
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TP53I11 HEPACAM2 SBK1 CD22 PRKCZ DNASE1L3	4.01e-05	166	168	6	3e3e9296e6919a38602e417a6606c046af3bd101
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TP53I11 HEPACAM2 SBK1 CD22 PRKCZ DNASE1L3	4.15e-05	167	168	6	3c3e1c31aacca48099693aea2efdfa22fc0e4af4
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TP53I11 HEPACAM2 SBK1 CD22 PRKCZ DNASE1L3	4.15e-05	167	168	6	77a4d7ce44847c76074d4f5340d61b398fe43e6c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPATA18 ITGA3 CR1 ITGAV CDC14A RYR3	4.29e-05	168	168	6	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	NPHP1 MYO9A ITGAV GALNT18 USP31 CAMSAP2	4.29e-05	168	168	6	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L MYO1B RSPH6A ADGRV1 ITGA3 PRKCZ	4.58e-05	170	168	6	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	UPB1 HEPACAM2 PFKP SGK2 TNNC2 DNASE1L3	4.58e-05	170	168	6	bf589c4297ccc90e5f51e3d0fcc229548af4fcef
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 CEBPA MYO9A APBA1 EGFR KCND1	4.89e-05	172	168	6	7fb31ccbcd0204c3612986a6bc20d57ed6825e9c
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 CEBPA MYO9A APBA1 EGFR KCND1	4.89e-05	172	168	6	2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TP53I11 MUC19 HEPACAM2 ADGRV1 CD22 DNASE1L3	5.56e-05	176	168	6	c6484334187f64cd00cd35e77d8ae436556b4260
ToppCell	mild-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TANC2 RIF1 PARP16 GYS1 PRKAR2B	5.84e-05	109	168	5	2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV CASQ1 PFKM CKMT2 TNNC2 MYBPC1	5.92e-05	178	168	6	69f68eeab11b088fcb1f963c92eff0f1cd0e711a
ToppCell	facs-Lung-Endomucin-24m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC29A3 CEBPA OLA1 USP31 MRPL41 DNASE1L3	6.11e-05	179	168	6	e520eadde4f1b7fb868dbbe94c4d62b3776c55eb
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GAK TP53I11 JMJD1C GALNT18 USP31 DNASE1L3	6.30e-05	180	168	6	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TIGD4 CASQ2 CKMT2 DNAH17 TNNC2 CDH6	6.30e-05	180	168	6	4fb95ed39508bede5472dd36aeabe91b33631726
ToppCell	Healthy-multiplets\|World / disease group, cell group and cell class	TANC2 APBA1 ACSF2 CLCN4 CDH2 DNASE1L3	6.49e-05	181	168	6	f8dbac3cd500cc8d80853312b00d124c27b8fd85
ToppCell	RV\|World / Chamber and Cluster_Paper	CKMT2 PPARGC1B PPP2R3A PLCL2 PRKAR2B CDH2	6.49e-05	181	168	6	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 CDC14A RLBP1 KANK1 SLCO1C1	6.49e-05	181	168	6	0c3f469bed108994ed696230e3c30343f7a301d3
ToppCell	droplet-Marrow-nan-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC29A3 UPB1 CEBPA ANXA6 APBA1 PLEC	6.69e-05	182	168	6	bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	APBA1 CR1 CDC14A RYR3 KANK1 PRKAR2B	6.90e-05	183	168	6	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	APBA1 CR1 CDC14A RYR3 KANK1 PRKAR2B	6.90e-05	183	168	6	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MYO1B ADGRV1 ITGA3 PTPN21 EGFR PRKCZ	6.90e-05	183	168	6	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	APBA1 ITGA3 CR1 CDC14A RYR3 PRKAR2B	6.90e-05	183	168	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
Drug	trifluoperazine	MYO9A ANXA6 CASQ1 CASQ2 MYO1B PFKM ADCY1 PHKA2 GYS1 PRKAR2B TNNC2 PRKCZ MYO15A THAP12	1.28e-07	324	167	14	CID000005566
Drug	netropsin	PFKL PFKM PFKP PHKA2 GYS1 DNASE1L1 TOP1	1.73e-07	56	167	7	CID000004461
Drug	sulfonamide analog 1	WDR81 BCKDHB PFKL ITGA3 PFKM PFKP GDI2 PHKA2 GYS1 PRKAR2B EIF2AK4	5.23e-07	213	167	11	CID005327336
Drug	Uridine diphosphate 2-deoxyglucose	PFKL PFKM PFKP	1.54e-06	4	167	3	CID000165519
Drug	isoproterenol	SAMD1 MYO9A GRK4 CASQ1 CASQ2 MYO1B PAF1 ADCY1 RYR3 CKMT2 P2RX1 CLCN4 GYS1 VCAN PRKAR2B TNNC2 PRKCZ MYO15A	2.22e-06	669	167	18	CID000003779
Drug	Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CA9 NPHP1 SIPA1L3 TP53I11 CASQ2 PTPN21 SGK2 RIF1 CLCN4 DNASE1L3	2.23e-06	199	167	10	2289_UP
Drug	M 16209	PFKL PFKM PFKP GYS1	3.58e-06	15	167	4	CID000164260
Drug	phosphonate analog	GOLGA6A PFKL PFKM PFKP ADCY1	4.02e-06	33	167	5	CID000475766
Drug	magnesium	RAD51D PDC PSMA1 LAMA1 CASQ2 MYO1B BCKDHB ADGRV1 PFKL PFKM PFKP ADCY1 RYR3 CKMT2 PHKA2 EGFR GYS1 VCAN DNAH17 PRKAR2B TNNC2 PRKCZ PLEC DNASE1L1 TOP1 DNASE1L3	4.26e-06	1325	167	26	CID000000888
Drug	AC1MIX9B	PFKL PFKM PFKP	7.63e-06	6	167	3	CID003081623
Drug	AC1L19C4	PFKL PFKM PFKP PPARGC1B GYS1 PRKAR2B	1.16e-05	69	167	6	CID000000483
Drug	glipentide	PFKL PFKM PFKP	1.33e-05	7	167	3	CID000065779
Drug	dactylarin	PFKL PFKM PFKP	1.33e-05	7	167	3	CID000161389
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	DGCR2 CEBPA SIPA1L3 CDC14A ITPR2 PLEC OSMR CDH6 LRRC41	1.56e-05	197	167	9	2849_DN
Drug	Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	CA9 DGCR2 UPB1 RASGRF1 TP53I11 CASQ2 RIF1 VCAN PLCL2	1.69e-05	199	167	9	5081_UP
Drug	lactosyl lysosphingolipid	GALC RYR3 EGFR	3.15e-05	9	167	3	CID006439268
Drug	AC1LIZYF	BCKDHB PFKL ITGA3 PFKM PPP2R3A GYS1 PRKAR2B EIF2AK4	3.63e-05	169	167	8	CID000914489
Drug	2,3,5-tri-O-benzyl-D-arabinofuranose	PFKL PFKM	5.35e-05	2	167	2	CID000255457
Drug	1-o-phosphonohex-2-ulose	PFKL PFKM PFKP GYS1	5.75e-05	29	167	4	CID000000481
Drug	fructose 2-phosphorothioate 6-phosphate	PFKL PFKM PFKP	6.12e-05	11	167	3	CID000195184
Drug	C14:1n-5	PFKL PFKM PFKP	6.12e-05	11	167	3	CID000068344
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SECISBP2L GALC STON1 SIPA1L3 PPP2R3A SLCO1C1 PLCL2 AHNAK2	6.63e-05	184	167	8	3244_UP
Drug	2,3-DPG	CPD ADGRV1 PFKL PFKM GYS1 VCAN PRKAR2B	6.96e-05	137	167	7	CID000000061
Drug	pyruvic acid	PDC UPB1 BCKDHB PFKL PFKM PFKP ADCY1 CKMT2 PHKA2 PPARGC1B GYS1 PLEC	7.28e-05	424	167	12	CID000001060
Drug	AC1L1IZ2	MYO9A MYO1B PFKM ADCY1 RYR3 PHKA2 CLCN4 EGFR PRKAR2B MYO15A	8.68e-05	304	167	10	CID000004795
Drug	3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A	N4BP2L1 CASQ2 CR1 ITPR2 RIF1 CLCN4 CD22 VCAN	8.93e-05	192	167	8	5624_UP
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A	SLC29A3 STON1 SIPA1L3 BCKDHB CR1 FAM13A VCAN CAMSAP2	8.93e-05	192	167	8	2947_DN
Drug	Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A	DGCR2 RASGRF1 TP53I11 CASQ2 SGK2 RIF1 EGFR CDH2	9.59e-05	194	167	8	4366_UP
Drug	Ethacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	N4BP2L1 MIA3 APBA1 CKMT2 PPARGC1B SLCO1C1 ADAMTS7 KCND1	9.94e-05	195	167	8	3181_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	STON1 SIPA1L3 BCKDHB PPP2R3A VCAN PLCL2 OSMR DNASE1L3	1.03e-04	196	167	8	5488_UP
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A	DGCR2 SIPA1L3 APBA1 TP53I11 P2RX1 ADAMTS7 VCAN PLCL2	1.03e-04	196	167	8	2270_UP
Drug	AH6809; Up 200; 1uM; PC3; HT_HG-U133A	STON1 SPOUT1 U2SURP BCKDHB CR1 CDC14A FAM13A CDH6	1.07e-04	197	167	8	7049_UP
Drug	1,5-Isoquinolinediol; Up 200; 100uM; HL60; HG-U133A	N4BP2L1 RALGAPB TP53I11 MYO1B RLBP1 PPP2R3A VPS33B LRRC41	1.07e-04	197	167	8	543_UP
Drug	Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A	SIPA1L3 APBA1 ITPR2 SNED1 PHKA2 CLCN4 VCAN CDH2	1.07e-04	197	167	8	2350_UP
Drug	1,6-di-o-phosphonohexopyranose	PFKL PFKM PFKP GYS1 VCAN	1.07e-04	64	167	5	CID000000737
Drug	Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	DGCR2 N4BP2L1 APBA1 TP53I11 SGK2 SNED1 CLCN4 CDH6	1.11e-04	198	167	8	4351_UP
Drug	Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A	NPHP1 STON1 BCKDHB PTPN21 CDC14A FAM13A VCAN OSMR	1.11e-04	198	167	8	3700_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; PC3; HT_HG-U133A	MIA3 BCKDHB CDC14A IBTK PPP2R3A VPS33B VCAN POFUT2	1.11e-04	198	167	8	6297_DN
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	STON1 TP53I11 PTPN21 CR1 CDC14A ITPR2 PLCL2 POFUT2	1.11e-04	198	167	8	4235_UP
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A	TANC2 N4BP2L1 SLC29A3 GALC CEBPA GRK4 APBA1 POFUT2	1.11e-04	198	167	8	4293_UP
Drug	1-(5-isoquinolinesulfonyl)-2-methylpiperazine	STON1 LAMA1 ADCY1 EGFR PRKAR2B AKAP11 PRKCZ PLEC THAP12 MYBPC1	1.13e-04	314	167	10	CID000003542
Drug	Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A	DGCR2 N4BP2L1 GRK4 PFKL ADAMTS7 CDH2 CDH6 DNASE1L3	1.14e-04	199	167	8	6093_UP
Drug	Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A	CA9 N4BP2L1 APBA1 TP53I11 RIF1 THBS2 CLCN4 CDH2	1.18e-04	200	167	8	4173_UP
Disease	glycogen storage disease (implicated_via_orthology)	PFKL PFKM PFKP	5.89e-07	4	157	3	DOID:2747 (implicated_via_orthology)
Disease	Glycogen Storage Disease	PFKL PFKM PHKA2 GYS1	1.23e-05	27	157	4	C0017919
Disease	red blood cell density measurement	CEBPA STON1 MYO9A HLA-DQB1 ADGRV1 PFKM JMJD1C ZNF106 FAM13A BAZ1A PLCL2 KDM4A EIF2AK4 PLEC MYO15A TOP1	2.01e-05	880	157	16	EFO_0007978
Disease	joint hypermobility measurement	STON1 BCKDHB THBS2 VCAN	2.80e-05	33	157	4	EFO_0007905
Disease	Nephronophthisis 1	NPHP1 IQCB1	2.81e-05	2	157	2	C4551979
Disease	nevus count, cutaneous melanoma	MIA3 STON1 ADGRV1 MED13L PPARGC1B	1.29e-04	91	157	5	EFO_0000389, EFO_0004632
Disease	Inherited acute myeloid leukemia	CEBPA TGM6	1.68e-04	4	157	2	C4707228
Disease	disease of metabolism (implicated_via_orthology)	PFKL PFKM PFKP	1.83e-04	21	157	3	DOID:0014667 (implicated_via_orthology)
Disease	post-operative atrial fibrillation, response to surgery	STON1 ADGRV1	2.78e-04	5	157	2	EFO_0009951, EFO_0009952
Disease	nephronophthisis (is_implicated_in)	NPHP1 IQCB1	4.16e-04	6	157	2	DOID:12712 (is_implicated_in)
Disease	basal cell carcinoma	STON1 RGS22 ADGRV1 PPARGC1B KANK1 MYO15A	5.41e-04	189	157	6	EFO_0004193
Disease	Senior-Loken syndrome (is_implicated_in)	NPHP1 IQCB1	5.80e-04	7	157	2	DOID:0050576 (is_implicated_in)
Disease	Abnormality of the eye	CDH2 MED13	5.80e-04	7	157	2	C4316870
Disease	Renal dysplasia and retinal aplasia	NPHP1 IQCB1	5.80e-04	7	157	2	cv:C0403553
Disease	bilirubin measurement	DCHS2 HLA-DQB1 SIPA1L3 ZNF407 JMJD1C SBK1 PPP2R3A SLCO1C1 TOP1	6.30e-04	442	157	9	EFO_0004570
Disease	alcohol use disorder (implicated_via_orthology)	GRK4 RIOX1 ADCY1 JMJD1C RYR3 EGFR	6.38e-04	195	157	6	DOID:1574 (implicated_via_orthology)
Disease	white matter integrity	STON1 HLA-DQB1 EGFR VCAN CDH2	6.71e-04	130	157	5	EFO_0004641
Disease	Disorder of eye	NPHP1 BBS2 ADGRV1 RLBP1 VCAN IQCB1	9.84e-04	212	157	6	C0015397
Disease	hepatitis B (is_implicated_in)	CA9 HLA-DQB1 EFTUD2	1.01e-03	37	157	3	DOID:2043 (is_implicated_in)
Disease	serum albumin measurement	HJV MIA3 HLA-DQB1 WDR81 ADGRV1 JMJD1C PRKAR2B EIF2AK4 PLEC RSBN1L	1.32e-03	592	157	10	EFO_0004535
Disease	reticulocyte measurement	CEBPA HLA-DQB1 U2SURP MYO1B POU5F1 PFKM UQCR10 JMJD1C CDH20 BAZ1A DNAH17 EIF2AK4 OSMR MYBPC1	1.54e-03	1053	157	14	EFO_0010700
Disease	mean fractional anisotropy measurement	STON1 EGFR VCAN PLEC	1.69e-03	95	157	4	EFO_0008399
Disease	Renal dysplasia and retinal aplasia (disorder)	NPHP1 IQCB1	1.79e-03	12	157	2	C0403553
Disease	mean corpuscular hemoglobin concentration	CEBPA STON1 TIGD4 MYO1B PFKM UQCR10 ITPR2 RIF1 EGFR BAZ1A PLCL2 EIF2AK4 MYO15A MED13	2.40e-03	1105	157	14	EFO_0004528
Disease	lung adenocarcinoma	SECISBP2L STON1 UBE4A ADAMTS7 BAZ1A	2.44e-03	174	157	5	EFO_0000571
Disease	Bardet-Biedl syndrome (is_implicated_in)	NPHP1 BBS2	2.45e-03	14	157	2	DOID:1935 (is_implicated_in)
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	ADCY1 CDC14A MYO15A	2.55e-03	51	157	3	cv:CN043650
Disease	cortical thickness	ABCF3 STON1 LAMA1 ADGRV1 JMJD1C ZNF106 CDH20 EGFR ADAMTS7 BAZ1A VCAN PRKCZ PLEC OSMR	2.56e-03	1113	157	14	EFO_0004840
Disease	fibrinogen measurement	DCHS2 JMJD1C PPP2R3A PLEC	2.78e-03	109	157	4	EFO_0004623
Disease	Ciliopathies	NPHP1 BBS2 ADGRV1 IQCB1	2.88e-03	110	157	4	C4277690
Disease	Hepatomegaly	SLC29A3 MYO1B ADAMTSL2	3.00e-03	54	157	3	C0019209
Disease	Small cell carcinoma of lung	ADCY1 EGFR TAF1L	3.00e-03	54	157	3	C0149925
Disease	Ischemic stroke, fibrinogen measurement	JMJD1C PPP2R3A PLEC	3.17e-03	55	157	3	EFO_0004623, HP_0002140
Disease	pyruvate measurement	PFKL PFKM PFKP CR1 CDH20 CDH2	3.20e-03	268	157	6	EFO_0010117
Disease	DiGeorge Syndrome	DGCR2 JMJD1C	3.21e-03	16	157	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	DGCR2 JMJD1C	3.21e-03	16	157	2	C0795907
Disease	Shprintzen syndrome	DGCR2 JMJD1C	3.21e-03	16	157	2	C0220704
Disease	lifestyle measurement, alcohol consumption measurement	CEBPA ACSF2 CSMD2 GALNT18	3.37e-03	115	157	4	EFO_0007878, EFO_0010724
Disease	Glycogen storage disease	PFKM PHKA2	3.63e-03	17	157	2	cv:C0017919
Disease	Graves disease, thyrotoxic periodic paralysis	DCHS2 HLA-DQB1	3.63e-03	17	157	2	EFO_0004237, MONDO_0019201
Disease	fibrinogen measurement, factor VII measurement	JMJD1C PPP2R3A PLEC	3.68e-03	58	157	3	EFO_0004619, EFO_0004623
Disease	keratinocyte carcinoma	STON1 RGS22 PPARGC1B KANK1	3.70e-03	118	157	4	EFO_0010176
Disease	cutaneous melanoma	STON1 ADGRV1 MED13L PPARGC1B	4.05e-03	121	157	4	EFO_0000389
Disease	lung carcinoma	SECISBP2L CDC14C STON1 HLA-DQB1 LAMA1 POU5F1 RIF1 ADAMTS7	4.41e-03	482	157	8	EFO_0001071
Disease	age at diagnosis, type 1 diabetes mellitus	HLA-DQB1 POU5F1 USP31	4.44e-03	62	157	3	EFO_0004918, MONDO_0005147
Disease	SARS-CoV-2 antibody measurement, response to COVID-19 vaccine	FAM89A MED13L MYBPC1	4.44e-03	62	157	3	EFO_0803360, EFO_0803362
Disease	anorectal malformation	CSMD2 THBS2	4.53e-03	19	157	2	MONDO_0019938
Disease	ovulation	RLBP1 KDM4A	4.53e-03	19	157	2	GO_0030728
Disease	transitional cell carcinoma (is_marker_for)	CA9 POU5F1 EGFR	4.65e-03	63	157	3	DOID:2671 (is_marker_for)
Disease	neuroimaging measurement	SECISBP2L DCHS2 HLA-DQB1 FRYL PTPN21 JMJD1C EFTUD2 ZNF106 EGFR BAZ1A VCAN PRKCZ PLEC	4.81e-03	1069	157	13	EFO_0004346
Disease	platelet crit	CEBPA STON1 U2SURP ZNF407 POU5F1 ADGRV1 JMJD1C ITPR2 P2RX1 EGFR KCND1 PLEC	5.06e-03	952	157	12	EFO_0007985

Protein segments in the cluster

Peptide	Gene	Start	Entry
DFPDDYNLGDIFLGV	YBEY	81	P58557
ALVFIDFQLEDGYDF	CSMD2	241	Q7Z408
TPEQLFAAYEDGFEQ	VCAN	181	P13611
EAIYGADFQDLRPDA	EIF2AK4	31	Q9P2K8
EELVYENFYADFGPL	CDC14A	41	Q9UNH5
EFPEIDGQVFDYVTG	ABCF3	11	Q9NUQ8
AIVSLYGEDAGDFFD	ADGRV1	66	Q8WXG9
EGDLYEDNLSFPTSD	AKAP11	1771	Q9UKA4
ELFQEFDYQPIAAAS	ADCK5	196	Q3MIX3
GGENIYPAELEDFFH	ACSF2	516	Q96CM8
FLDEPFPDVGTYEDF	CLCN4	16	P51793
EYENFSEDFGPLNLA	CDC14C	51	A4D256
FQLSNEDYFIEPLDS	ADAMTS7	156	Q9UKP4
NAFGELFDLQDEFPD	BAZ1A	436	Q9NRL2
AAFLEEGPEENSAYE	CA9	276	Q16790
DFPGFDPNQDAEALY	ANXA6	16	P08133
DAAGQFFPEAAQVAY	ANXA6	326	P08133
FSAFPVNGADLYEEL	RAD51D	61	O75771
LAFPDQLYDAVFDGA	TP53I11	81	O14683
NGEYFLSELEPATEY	OSMR	386	Q99650
FFERAFDQGADAIYD	UQCR10	31	Q9UDW1
YQAEVDNLPVAFEDG	HJV	236	Q6ZVN8
PQELGAAGEQDVFYE	GOLGA6A	641	Q9NYA3
AADEPVYIAGQQAFF	HNRNPLL	131	Q8WVV9
AALQLEYFFTAGPDE	OLA1	301	Q9NTK5
NLAVALFYPFGDDGD	ITPR2	2241	Q14571
EYFGAFGEIENIELP	HNRNPDL	251	O14979
DYIFPAFDQIVNEAA	BCKDHB	151	P21953
IYDGIDSNFEPELVF	RSPH10B	611	P0C881
IYDGIDSNFEPELVF	RSPH10B2	611	B2RC85
YVANFDEKDPRTFEG	GDI2	146	P50395
IQAFDEELAFYGLVP	KCND1	111	Q9NSA2
GDSLGEVNDPYTFED	MED13L	706	Q71F56
INSGNIPDYLFDFFE	NLRC4	586	Q9NPP4
LDSLFDPVLSYGDAD	MYO15A	2391	Q9UKN7
IQDLLVFYEAFGNPE	IBTK	1316	Q9P2D0
PLDIAYGADGEVFND	SPATA18	436	Q8TC71
LDFLTEDSAFQPYQD	JMJD1C	136	Q15652
PDQEGISDADFVLYV	LMLN	201	Q96KR4
ERAFVNPFPDYEAAA	LANCL2	21	Q9NS86
EFFAGDVESFLNEYG	PDC	211	P20941
DENFYPDLLVGSLSD	ITGA3	441	P26006
FNNTDYEIGASFDDP	MUC19	8231	Q7Z5P9
AVGADAAYVFEDPFN	PFKL	586	P17858
LAAGADAAYIFEEPF	PFKM	586	P08237
LAAGADAAYIFEEPF	PFKP	596	Q01813
LDYNFTAGINDFIPD	FRYL	1686	O94915
GIEADDNPFFDLSVY	DUSP13	101	Q9UII6
LAENYSELAEAFGEP	KANK1	841	Q14678
NFDDGSFSDNLYPED	KDM4A	931	O75164
DYAIIFTQLEFGDEP	LCN6	116	P62502
FVDYEENEGAGPYLL	ADAMTSL2	496	Q86TH1
NFPGYFDEVINADDL	LRGUK	571	Q96M69
FTIYDDDDVSPFLEG	PSMA1	221	P25786
PALFDEVAIYFSDEE	POGK	46	Q9P215
FLDQFEDDADGFISP	FAM13A	911	O94988
QFQEGFEDYETDEPA	PPP2R3A	1106	Q06190
LLEREDFFPDYEENG	PAIP1	426	Q9H074
DYAQREDFEAAGSPF	POU5F1	291	Q01860
LAVQADFGDFDQYES	PTPN21	146	Q16825
EEFIGFLPYEADAEI	THAP12	291	O43422
EGIDEFEPIFTQDQY	DCHS2	2871	Q6V1P9
APDFLFEIEYFDPAN	PARP16	121	Q8N5Y8
ADFLSEAALEENPYF	OSBPL8	446	Q9BZF1
DEEGNQFVAYFLPVE	PAF1	251	Q8N7H5
LAEGGFAFVYEAQDV	GAK	46	O14976
EGRDSPEDFVYQFKA	HLA-DQB1	31	P01920
VDADEYLIPQQGFFS	EGFR	1011	P00533
FASIPNFNDFYIELD	ADCY1	871	Q08828
VLQDPQSGEYFVFDL	CEFIP	1276	Q711Q0
LDPDLYQDFCAGAFD	CXXC1	286	Q9P0U4
AIEDLQVEADFPVYF	BBS2	576	Q9BXC9
YNDEDDVFAREPFVA	DNASE1L1	116	P49184
DYQDGDADVFSREPF	DNASE1L3	121	Q13609
NLTDEFEFPIGTYLN	CR1	56	P17927
PGDSNFDRDYADFEI	DNAH17	481	Q9UFH2
DVNDNAPEFPRFYEA	CDH20	486	Q9HBT6
AASREDFELQGYAFE	UPB1	46	Q9UBR1
AYIDPAAFNDEFLAD	CEBPA	66	P49715
AQPGVLFFADDDNTY	B3GAT2	176	Q9NPZ5
AFEDAAEEFHPYIPF	CASQ1	196	P31415
NGDDYADVFIGAPLF	ITGAV	316	P06756
FPDTLEGFEYAFNEK	FAM172A	56	Q8WUF8
DNFEIEEYPLAAQGF	GALNT18	286	Q6P9A2
VVNYPFDDDEQGLAT	CPD	676	O75976
SPLSDYGEEELFIFQ	DNAAF8	41	Q8IYS4
DPEDLIDGIIFAANY	APBA1	451	Q02410
FDFAAQPVDEVPFYI	CRYM-AS1	56	A6NIL9
DNVVDEGFYFTPKGD	DGCR2	276	P98153
EEFYNELLPSAAENF	IQCB1	101	Q15051
PQELGAAGEQDVFYE	GOLGA6D	641	P0CG33
DDGDNFYVIDRGTFD	PRKAR2B	186	P31323
VAFAEKSDPDGYEFL	CASQ2	271	O14958
VNDNAPEFAEFYETF	CDH6	481	P55285
LDDFGIYEFVAFPDV	HEPACAM2	406	A8MVW5
FYEQPDEDGTLGFRA	HELZ2	1506	Q9BYK8
NPGFDEQRAVFYAAE	GRK4	281	P32298
AFPEHFTYEPNEADA	GYS1	616	P13807
KDDFNVDYPFFSEAP	GALC	491	P54803
DVVEYFTEAGFPEQA	SAMD1	466	Q6SPF0
FAQEYAPAGDLFDII	SBK1	126	Q52WX2
AFFQATDLPYDIEDA	CAMSAP2	166	Q08AD1
LDYDIDPNAGPFAFD	CDH2	626	P19022
GDLESFILFHNPEYN	CD22	51	P20273
SAVFAEAPFQDGYDL	SPOUT1	271	Q5T280
HEPFDLSEQTYDFLG	NPHP1	711	O15259
FSPDSDSDLVGYLED	PHKA2	636	P46019
GDEESYEVFADLFDP	CKMT2	111	P17540
YEALQAFDFRVGASD	PCDHB9	521	Q9Y5E1
LDFGETAVLDAFYDA	MAP3K15	106	Q6ZN16
DVADYVFPAQGDNSF	P2RX1	86	P51575
PLGFYQFSEEEGDEE	RSPH6A	496	Q9H0K4
AVDEEVGDYFPEFLD	RSBN1L	471	Q6PCB5
GEDPEGSDILNYFES	SLC29A3	91	Q9BZD2
DGTFDPDNLEKYGFE	MRPL41	106	Q8IXM3
PAPFYLFDEIDQALD	SMC3	1136	Q9UQE7
AFLGFSYAPEDDDIL	SGK2	351	Q9HBY8
GFAFVEYEVPEAAQL	PUF60	171	Q9UHX1
ATDYSDPDNVDDGLF	MIA3	431	Q5JRA6
PGAESEDLYDFVFIV	LRRC41	406	Q15345
EYEQFIAESGGPFID	POFUT2	121	Q9Y2G5
YGVFEVANDAPQFLE	RGS22	51	Q8NE09
PDNILEFAADYFTDP	RIIAD1	61	A6NNX1
FADPIYQAGLADDID	RIF1	2206	Q5UIP0
GYGEKSFFAPEEENE	TAF1L	921	Q8IZX4
PDCTYALENGFFDEE	FAM89A	131	Q96GI7
ALENGFFDEEEEYFQ	FAM89A	136	Q96GI7
TEGVYYQAPDFLLDA	LAMA1	1191	P25391
GDAPIFDESFEFQIN	PLCL2	806	Q9UPR0
AEEDGYTLFVAGFED	MFAP4	156	P55083
GEEQLYADFPELDLS	PPARGC1B	31	Q86YN6
YNNEEAGPAFEEFLS	SIPA1L3	641	O60292
DLAAFYGDAEVVQFL	TANC2	1171	Q9HCD6
DPNSESLYFEDEDGF	SECISBP2L	381	Q93073
DPYAFVEGDEEFLFP	MED13	696	Q9UHV7
FADDISEDDPFLLYA	PRORP	471	O15091
DLAFIEEGTPNYTED	RASGRF1	1196	Q13972
GFAPHYDDIEAFVLQ	RIOX1	336	Q9H6W3
VALADFYPFGAERGD	SNED1	26	Q8TER0
IYEEFLAAFEGSDGN	U2SURP	116	O15042
YTTEAADFGLQEDAP	AHNAK2	61	Q8IVF2
EDGVHFQSYPFDFLE	ZNF865	21	P0CJ78
DLIDIGFGYDETDPF	UBN2	201	Q6ZU65
DLELGVDNSAFYDQF	TMEM179	156	Q6ZVK1
LQFDNPAELYVEDTG	NHLRC3	161	Q5JS37
ESLGFQSDDLPQFQY	STON1	161	Q9Y6Q2
LAFADYEIENGFVPI	RYR3	1176	Q15413
PLGIAYLDDFASEDN	SLCO1C1	206	Q9NYB5
FPEGLSIEEYAALDD	TIGD4	411	Q8IY51
DPFLFNIDFVDDSYL	ZBED8	476	Q8IZ13
RFDDLSGEYNPEVFD	RRP36	121	Q96EU6
FYQEIDENILPSDFG	RLBP1	276	P12271
GFFDPNTEENLTYLQ	PLEC	4226	Q15149
DASEFPDNYEAGRAE	RALGAPB	501	Q86X10
NADGYIDPEELAEIF	TNNC2	106	P02585
EAEAAGPELEASYVF	TPBGL	296	P0DKB5
ELNAISGPNEFAEFY	SF3A3	71	Q12874
DFLFVNTEDEYIPDA	USP31	566	Q70CQ4
VIIFQGYDGEFALDP	ZNF407	1866	Q9C0G0
LAYVPEFFADNLGDF	UBE4A	621	Q14139
DSFALDEPFYEHLQA	THBS2	171	P35442
YDEFGNYIGPELDSD	EFTUD2	6	Q15029
PELDGQEYVVEFDFL	TOP1	516	P11387
FPSEGLLDFNFEQLE	ZNF106	306	Q9H2Y7
HDGPFVFAEVNADYI	TGM6	386	O95932
GPEFLTYFQNEAQLD	TRBV7-8	61	A0A1B0GX51
QADLPETEDFQAGLY	WDR81	1076	Q562E7
ELPEFFRDYFLEGDQ	VPS33B	156	Q9H267
QQEEPSEFDLAYADF	XKR8	111	Q9H6D3
YYLALDAPDNEVGFL	GARIN5B	131	Q8N5Q1
DQSEFEGFEYINPLL	PRKCZ	571	Q05513
LDIYGFEIFEDNSFE	MYO1B	386	O43795
EGLEVPFIDSLYEFN	NLRP13	506	Q86W25
EDGAYEFNPDFLEEA	N4BP2L1	81	Q5TBK1
LDIFGFEDYENNSFE	MYO9A	536	B2RTY4
ANALTEDEGDYVFAP	MYBPC1	491	Q00872